Short-term effect of fenofibrate on C-reactive protein: A meta-analysis of randomized controlled trials
<p>Abstract</p> <p>Background</p> <p>C-reactive protein (CRP) is positively associated with risk for cardiovascular disease and all-cause mortality. Some but not all randomized and non-randomized clinical trials found significant associations between fenofibrate therapy...
Main Authors: | Ye Jiatao, Kiage James N, Arnett Donna K, Bartolucci Alfred A, Kabagambe Edmond K |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-09-01
|
Series: | Diabetology & Metabolic Syndrome |
Subjects: | |
Online Access: | http://www.dmsjournal.com/content/3/1/24 |
Similar Items
-
Comparison of efficacy and safety of choline fenofibrate (fenofibric acid) to micronized fenofibrate in patients of mixed dyslipidemia: A randomized, open-label, multicenter clinical trial in Indian population
by: Piyush Patel, et al.
Published: (2016-01-01) -
Development and validation of bioanalytical UHPLC-UV method for simultaneous analysis of unchanged fenofibrate and its metabolite fenofibric acid in rat plasma: Application to pharmacokinetics
by: Rayan G. Alamri, et al.
Published: (2017-01-01) -
Comparison of efficacy and safety of fixed dose combination of rosuvastatin and choline fenofibrate to fixed dose combination of rosuvastatin and fenofibrate in patients of mixed dyslipidemia: A randomized, open-label, multicentre clinical trial in Indian population
by: Hanmant Barkate, et al.
Published: (2018-01-01) -
Fenofibrate-induced renal dysfunction, yes or no?
by: Fatemeh Emami, et al.
Published: (2020-01-01) -
Effect of Fenofibrate on Neonatal Hyperbilirubinemia: A Systematic Review and Meta-analysis
by: Nasrin Zamiri-Miandoab, et al.
Published: (2021-07-01)